Product name | Recombinant Human IL-17RA/CD217 Protein |
---|---|
Catalog No. | RP00273 |
Description | Recombinant Human IL-17RA/CD217 Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Leu33-Trp320) of human IL17RA (Accession #NP_055154.3) fused with a 6×His tag at the C-terminus. |
Bio-Activity | 1.Measured by its ability to inhibit IL-17A induced IL-6 secretion by Hela cells. The ED50 for this effect is 0.02 0.1 μg/mL in the presence of 10 ng/mL recombinant human IL 17A. 2.Measured by its binding ability in a functional ELISA. Immobilized Recombinant human IL17RA , His Tag at 2 μg/mL (100 μL/well) can bind Recombinant human IL-17A, His Tag with a linear range of 31.25-65 ng/mL. |
Purity | > 95% by SDS-PAGE. |
Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
Species | Human |
Calculated MW | 34.29 kDa |
Synonym | CANDF5; CD217; CDw217; IL-17RA; IL17R; IMD51; hIL-17R; IL17RA; CD217; CDw217; IL-17RA; IL17R; IMD51; hIL-17R |
---|---|
Expression Host | HEK293 cells |
Tag | C-His |
Swiss-Prot | |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
* For research use only. Not for therapeutic or diagnostic purposes.